ID

21504

Descrição

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00416312

Link

https://clinicaltrials.gov/show/NCT00416312

Palavras-chave

Versões (1)
  1. 25/04/2017 25/04/2017 -
Transferido a

25 de abril de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Lymphoma NCT00416312

Inglês

Eligibility Lymphoma NCT00416312

1 Formulários  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00416312
Criteria
Descrição

Criteria

diagnosis of non-hodgkin's lymphoma
Descrição

Lymphoma, Non-Hodgkin

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0024305
measurable disease by ct scan or nuclear medicine imaging
Descrição

Measurable Disease X-Ray Computed Tomography | Measurable Disease Radionuclide Imaging

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0040405
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0034606
eligible, by standard of care criteria, for iodine i 131 tositumomab or yttrium y 90 ibritumomab tiuxetan treatment
Descrição

Standard of Care criteria | Iodine-131 [I-131] tositumomab | yttrium-90-ibritumomab tiuxetan

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2936643
UMLS CUI [1,2]
C0243161
UMLS CUI [2]
C1260363
UMLS CUI [3]
C1134535
patient characteristics:
Descrição

Client Characteristics

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0815172
no other malignancy within the past 3 years except basal cell carcinoma or squamous cell carcinoma of the skin or in situ carcinoma of the cervix
Descrição

Malignant Neoplasms Absent | Basal cell carcinoma | Squamous cell carcinoma of skin | Carcinoma in situ of uterine cervix

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0553723
UMLS CUI [4]
C0851140
not pregnant or nursing
Descrição

Pregnancy Absent | Breast Feeding Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
fertile patients must use effective contraception
Descrição

Fertility Contraceptive methods

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no alcoholism or drug abuse within the past 2 years
Descrição

Chronic Alcoholic Intoxication Absent | Drug abuse Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0001973
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0013146
UMLS CUI [2,2]
C0332197
no severe emotional, behavioral, or psychiatric problems that would limit study compliance
Descrição

Emotional problems Severe Absent | Behaviorial problem Severe Absent | Psychiatric problem Severe Absent | Mental problem Protocol Compliance Limited

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0677660
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0233514
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C1306597
UMLS CUI [3,2]
C0205082
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C0848067
UMLS CUI [4,2]
C0525058
UMLS CUI [4,3]
C0439801
prior concurrent therapy:
Descrição

Therapeutic procedure

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0087111
no concurrent participation in another investigational drug study
Descrição

Study Subject Participation Status Exclusion | Investigational New Drugs Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C2828389
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0332197
Voltar ao início da página

Similar models

Eligibility Lymphoma NCT00416312

1 Formulários
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00416312
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Lymphoma, Non-Hodgkin
Item
diagnosis of non-hodgkin's lymphoma
boolean
C0024305 (UMLS CUI [1])
Measurable Disease X-Ray Computed Tomography | Measurable Disease Radionuclide Imaging
Item
measurable disease by ct scan or nuclear medicine imaging
boolean
C1513041 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C0034606 (UMLS CUI [2,2])
Standard of Care criteria | Iodine-131 [I-131] tositumomab | yttrium-90-ibritumomab tiuxetan
Item
eligible, by standard of care criteria, for iodine i 131 tositumomab or yttrium y 90 ibritumomab tiuxetan treatment
boolean
C2936643 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1260363 (UMLS CUI [2])
C1134535 (UMLS CUI [3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Malignant Neoplasms Absent | Basal cell carcinoma | Squamous cell carcinoma of skin | Carcinoma in situ of uterine cervix
Item
no other malignancy within the past 3 years except basal cell carcinoma or squamous cell carcinoma of the skin or in situ carcinoma of the cervix
boolean
C0006826 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
C0851140 (UMLS CUI [4])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Chronic Alcoholic Intoxication Absent | Drug abuse Absent
Item
no alcoholism or drug abuse within the past 2 years
boolean
C0001973 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0013146 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Emotional problems Severe Absent | Behaviorial problem Severe Absent | Psychiatric problem Severe Absent | Mental problem Protocol Compliance Limited
Item
no severe emotional, behavioral, or psychiatric problems that would limit study compliance
boolean
C0677660 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0233514 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C1306597 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0848067 (UMLS CUI [4,1])
C0525058 (UMLS CUI [4,2])
C0439801 (UMLS CUI [4,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Study Subject Participation Status Exclusion | Investigational New Drugs Absent
Item
no concurrent participation in another investigational drug study
boolean
C2348568 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial